Trustees of Columbia University in the City of New York’s Vigil Neuroscience VIGL Stock Holding History

Trustees of Columbia University in the City of New York’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-192,973	Closed	-$1.53M	–	10
2025 Q2	$1.53M	Hold	192,973	–	–	0.22%	2
2025 Q1	$343K	Hold	192,973	–	–	0.05%	4
2024 Q4	$328K	Buy	+192,973	New	+$570K	0.05%	7
2023 Q4	$652K	Hold	192,973	–	–	1.38%	5
2023 Q3	$1.04M	Hold	192,973	–	–	1.91%	5
2023 Q2	$1.81M	Hold	192,973	–	–	2.66%	5
2023 Q1	$1.89M	Hold	192,973	–	–	3.38%	6
2022 Q4	$2.41M	Buy	+192,973	New	+$2.37M	4.97%	2

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Trustees of Columbia University in the City of New York's VIGL Position: Q3 2025 in Review

Trustees of Columbia University in the City of New York sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 192,973 shares — an estimated $1.53M sold.

Trustees of Columbia University in the City of New York first reported a position in VIGL in Q4 2022 and held it in 8 quarters. The position peaked at $2.41M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Trustees of Columbia University in the City of New York reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Trustees of Columbia University in the City of New York sold 192,973 Vigil Neuroscience shares in Q3 2025, an estimated $1.53M.
Trustees of Columbia University in the City of New York first reported a position in Vigil Neuroscience in Q4 2022 and held it in 8 quarters.
Trustees of Columbia University in the City of New York's Vigil Neuroscience position peaked at $2.41M in Q4 2022.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q3 2025, filed 14 Nov 2025.